Researchers from Harvard, MIT, the Ragon Institute of MGH, Brigham and Women’s Hospital and Massachusetts General Hospital recently conducted a study that discovered that the new mRNA coronavirus vaccines were highly efficacious in producing antibodies against the SARS-CoV-2 virus in lactating and pregnant women. The researchers also showed that the vaccines offered protective immunity to newborns through the placenta and breast milk.
Their findings were reported in the “American Journal of Obstetrics and Gynecology” and observed 131 women, 16 of whom weren’t pregnant, 31 who were lactating and 84 who were pregnant, all of reproductive age. All the study participants received one of the two new mRNA vaccines: Moderna or Pfizer/BioNTech. The antibodies were found to be equal in all three groups. Additionally, any side effects observed after the vaccines…
NOTE TO INVESTORS: The latest news and updates relating to Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) are available in the company’s newsroom at https://ibn.fm/IMEXF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.